The US Food and Drug Administration (FDA) has approved generic versions of Gilenya, a multiple sclerosis (MS) medication.

A recent study found a possible link between organic solvents and increased multiple sclerosis (MS) risk in people with genes that make them more susceptible to developing the condition.

The US Food and Drug Administration (FDA) has expanded the approval of a multiple sclerosis (MS) medication to treat the condition in children.

A multiple sclerosis treatment is being withdrawn from the market, according to the US Food and Drug Administration (FDA).

Mothers who breastfeed their children longer may be less likely to develop multiple sclerosis (MS), according to a new study.

A newly approved multiple sclerosis (MS) medication is the first ever approved by the US Food and Drug Administration (FDA) to treat a particular type of MS.

A multiple sclerosis (MS) medication appeared to reduce some physical disability caused by the disease, according to a new study.

Beginning to take medication to treat multiple sclerosis (MS) at the early signs might slow the disease's progression, a new study found.

Obesity in early adulthood may be linked to an increased risk of multiple sclerosis (MS), a new study found.